Pragmatic Trials for Noncommunicable Diseases: Relieving Constraints.
- Publisher:
- PUBLIC LIBRARY SCIENCE
- Publication Type:
- Journal Article
- Citation:
- PLoS medicine, 2016, 13, (3), pp. e1001986
- Issue Date:
- 2016-03-29
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Patel, A | |
dc.contributor.author |
Webster, R https://orcid.org/0000-0002-7444-3037 |
|
dc.date.accessioned | 2020-05-04T05:20:00Z | |
dc.date.available | 2020-05-04T05:20:00Z | |
dc.date.issued | 2016-03-29 | |
dc.identifier.citation | PLoS medicine, 2016, 13, (3), pp. e1001986 | |
dc.identifier.issn | 1549-1277 | |
dc.identifier.issn | 1549-1676 | |
dc.identifier.uri | http://hdl.handle.net/10453/140459 | |
dc.description.abstract | In this month's editorial, PLOS Medicine Editorial Board member Anushka Patel and Ruth Webster discuss how applying rules for drug efficacy trials can impede pragmatic trials of interventions for noncommunicable diseases. | |
dc.format | Electronic-eCollection | |
dc.language | eng | |
dc.publisher | PUBLIC LIBRARY SCIENCE | |
dc.relation.ispartof | PLoS medicine | |
dc.relation.isbasedon | 10.1371/journal.pmed.1001986 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | 11 Medical and Health Sciences | |
dc.subject.classification | General & Internal Medicine | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Hypertension | |
dc.subject.mesh | Diabetes Mellitus | |
dc.subject.mesh | Obesity | |
dc.subject.mesh | Alcohol Drinking | |
dc.subject.mesh | Research | |
dc.subject.mesh | Research Design | |
dc.subject.mesh | World Health Organization | |
dc.subject.mesh | Sedentary Lifestyle | |
dc.subject.mesh | Translational Medical Research | |
dc.subject.mesh | Tobacco Use | |
dc.subject.mesh | Pragmatic Clinical Trials as Topic | |
dc.subject.mesh | Alcohol Drinking | |
dc.subject.mesh | Diabetes Mellitus | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Hypertension | |
dc.subject.mesh | Obesity | |
dc.subject.mesh | Pragmatic Clinical Trials as Topic | |
dc.subject.mesh | Research | |
dc.subject.mesh | Research Design | |
dc.subject.mesh | Sedentary Behavior | |
dc.subject.mesh | Tobacco Use | |
dc.subject.mesh | Translational Medical Research | |
dc.subject.mesh | World Health Organization | |
dc.title | Pragmatic Trials for Noncommunicable Diseases: Relieving Constraints. | |
dc.type | Journal Article | |
utslib.citation.volume | 13 | |
utslib.location.activity | United States | |
utslib.for | 11 Medical and Health Sciences | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Business | |
pubs.organisational-group | /University of Technology Sydney | |
utslib.copyright.status | open_access | * |
dc.date.updated | 2020-05-04T05:19:59Z | |
pubs.issue | 3 | |
pubs.publication-status | Published | |
pubs.volume | 13 | |
utslib.start-page | e1001986 | |
utslib.citation.issue | 3 |
Abstract:
In this month's editorial, PLOS Medicine Editorial Board member Anushka Patel and Ruth Webster discuss how applying rules for drug efficacy trials can impede pragmatic trials of interventions for noncommunicable diseases.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph